Compounds > resveratrol
Page last updated: 2024-08-16

resveratrol and erlotinib hydrochloride

resveratrol has been researched along with erlotinib hydrochloride in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Hou, B; Hu, W; Nie, P; Yang, Y; Zhang, T; Zou, Z1
Abbaspour-Ravasjani, S; Asadollahi, L; Dorreyatim, SS; Hamishehkar, H; Mahoutforoush, A; Paiva-Santos, AC; Peixoto, D; Soltanfam, T; Veiga, F; Zeinali, M1
Al Hroot, J; Al-Husein, B; Mayyas, A; Zayed, A1

Other Studies

3 other study(ies) available for resveratrol and erlotinib hydrochloride

ArticleYear
Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, Volume: 35, Issue:6

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Line, Tumor; Down-Regulation; Drug Synergism; Erlotinib Hydrochloride; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Resveratrol; Ribosomal Protein S6 Kinases; Signal Transduction; Stilbenes; Survivin; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53; Up-Regulation

2015
Co-Delivery of erlotinib and resveratrol via nanostructured lipid Carriers: A synergistically promising approach for cell proliferation prevention and ROS-Mediated apoptosis activation.
    International journal of pharmaceutics, 2022, Aug-25, Volume: 624

    Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Drug Carriers; Erlotinib Hydrochloride; Humans; Lipids; Lung Neoplasms; Nanostructures; Particle Size; Reactive Oxygen Species; Resveratrol

2022
Rapid high performance liquid chromatography method for erlotinib quantification in vitro: Application to study the effect of resveratrol on metabolism and cellular uptake of erlotinib.
    Fundamental & clinical pharmacology, 2023, Volume: 37, Issue:5

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Microsomes, Liver; Rats; Resveratrol

2023